Insights

Given the critical importance of support offerings to shape and improve the patient experience, as well as the millions of dollars in investment, it is critical to understand if your

In the next installment of our Envision series, we highlight the impact our treatment experience blueprint can provide to an organization. A treatment experience blueprint provides a single source of

As we navigate the complex landscape of healthcare, one issue stands out: health equity. It’s a multifaceted challenge that transcends age, ethnicity, gender, geography, race, and other social determinants of

Caregivers are often overlooked during a patient’s treatment plan, leading to unheard voices and unaddressed needs. In honor of Caregiver Awareness Day on February 16th , Nuvera is excited to

Nuvera would like to congratulate our team on their engaging and informative presentations at the Patient Support Services Congress last week. It is always exciting to see a fully captive

Bristol Myers Squibb and Genentech won their respective therapeutic areas for this year’s annual award. Nuvera Life Science Consulting is pleased to announce its third annual awards for the pharmaceutical

Nuvera’s own Greg Christianson and John Valdes hosted an informative webinar earlier this month which explored levels of maturity in patient support capabilities.

Will your technology infrastructure enable the success of your #CellTherapy? In this final installment of Nuvera’s Autologous Cell Therapy (ACT) infographic series, we address the likely systems and databases that

How easy is it to order your #celltherapy? Unlike off-the-shelf products, Autologous Cell Therapies are made to order for each individual patient – successful   and seamless delivery will depend